34 research outputs found

    Reconciling the professional and student identities of clinical psychology trainees

    Get PDF
    The study explored the ways in which qualified and trainee clinical psychologists perceived professional behaviour, as illustrated in a series of short vignettes, in student and clinical practice contexts. Comparisons were made to identify the extent to which ideas of professionalism differed across different learning contexts and between qualified and unqualified staff, with the aim of adding to the literature on which factors influence the development of professional identity in health professionals. An online questionnaire depicting a range of potentially unprofessional behaviours was completed by 265 clinical psychology trainees and 106 qualified clinical psychologists. The data were analysed using a general linear model with simultaneous entry in which rater (trainee vs qualified clinical psychologist), setting (student vs placement) and their interaction predicted acceptability ratings. We found that, in general, trainees and qualified staff agreed on those behaviours that were potentially unprofessional, although where significant differences were found, these were due to trainees rating the same behaviours as more professionally acceptable than qualified clinical psychologists. Despite trainees identifying a range of behaviours as professionally unacceptable, some percentage reported having engaged in a similar behaviour in the past. Irrespective of the status of the rater, the same behaviours tended to be viewed as more professionally unacceptable when in a placement (clinical) setting than in a student (university) setting. Generally, no support was found for a rater by setting interaction. The study suggests that trainee clinical psychologists are generally successful at identifying professional norms, although they do not always act in accordance with these. Conflicting student and professional norms may result in trainees viewing some potentially unprofessional behaviour as less severe than qualified staff. Health professional educators should be aware of this fact and take steps to shape trainee norms to be consistent with that of the professional group

    Autonomic logistics-the support concept for the 21/sup st/ century

    No full text

    Correlating Ki67 and other prognostic markers with oncotype DX recurrence score in early breast cancer

    No full text
    Background: Breast cancer is a common problem. Decisions regarding adjuvant chemotherapy are complex. Ki67 is increasingly used, in conjunction with conventional prognostic markers, to help decide the use of adjuvant chemotherapy for early breast cancer. Ki67 may be an economical alternative to Oncotype DX recurrence score (RS), which is a validated prognostic marker for disease recurrence and predictive marker for benefit from chemotherapy. Methods: We reviewed all cases of luminal type early breast cancer (T1–2, N0–1mi, M0, ER positive, HER2 negative) referred for Oncotype DX testing (n = 58) at an Australian tertiary private hospital from 14 December 2006 to 31 December 2013. RS was correlated with Ki67, along with other conventional prognostic markers including tumour size, grade, mitotic rate and lymphovascular invasion. Spearman's rank order correlation coefficient and Pearson product-moment correlation coefficient (r) were used for ordinal and continuous variables respectively. Results: The median Ki67 was 15% (range 2–50), the median RS was 16 (range 3–65). There was no positive correlation between Ki67 and RS (r = 0.012, P = 0.929). No single conventional prognostic marker was shown to significantly correlate with RS, including tumour size (r = −0.021, P = 0.878), grade (r = 0.103, P = 0.442), mitotic rate (r = −0.072, P = 0.692) and lymphovascular invasion (r = −0.124, P = 0.385). Conclusions: Ki67 and conventional prognostic markers do not correlate with Oncotype DX recurrence score. In the setting where conventional prognostic markers do not show a clear indication for or against adjuvant chemotherapy, Ki67 is not a substitute for Oncotype DX testing.1 page(s
    corecore